Cubicin and Meloxicam drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cubicin and Meloxicam. Common interactions include adjustment disorder among females and osteomyelitis among males.

The phase IV clinical study analyzes what interactions people who take Cubicin and Meloxicam have. It is created by eHealthMe based on reports of 18 people who take Cubicin and Meloxicam from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 09, 2023

18 people who take Cubicin and Meloxicam together, and have interactions are studied.

What is Cubicin?

Cubicin has active ingredients of daptomycin. It is often used in infection. eHealthMe is studying from 7,514 Cubicin users for its effectiveness, alternative drugs and more.

What is Meloxicam?

Meloxicam has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 58,068 Meloxicam users for its effectiveness, alternative drugs and more.

Number of Cubicin and Meloxicam reports submitted per year:

Common Cubicin and Meloxicam drug interactions by gender *:

female:

Adjustment disorder
Dysfunctional uterine bleeding
Bacterial infection
Bone neoplasm malignant
Breast cancer
Affective disorder
Anaemia
Anhedonia
Anxiety
Arteriosclerosis

male:

Osteomyelitis
Staphylococcal infection
Eosinophilic pneumonia acute
Anaphylactic reaction
Asthenia
Influenza like illness
Intervertebral discitis
Pyrexia

Common Cubicin and Meloxicam drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Blood calcium decreased
Blood creatine phosphokinase increased
Fistula
Oral candidiasis

50-59:

Anaphylactic reaction

60+:

C-reactive protein increased
Bacterial infection
Adjustment disorder
Affective disorder
Anaemia
Anhedonia
Anxiety
Arteriosclerosis
Arthralgia
Atelectasis

Common conditions people have *:

High Blood Pressure: 6 people, 33.33%
Breast Cancer Metastatic: 4 people, 22.22%
High Blood Cholesterol: 4 people, 22.22%
Metastases To Bone (cancer spreads to bone): 4 people, 22.22%
Arthritis Infective (purulent invasion of a joint by an infectious agent which produces arthritis): 3 people, 16.67%
Insomnia (sleeplessness): 2 people, 11.11%
Depression: 2 people, 11.11%
Enterococcal Infection: 2 people, 11.11%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 11.11%
Neoplasm Malignant (cancer tumour): 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Cubicin and Meloxicam?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Lai SW, Lin CL, Liao KF, "Association of Meloxicam Use with the Risk of Acute Pancreatitis: A Case–Control Study", Clinical drug investigation, 2015 Oct .
Saliho?lu M, Turhan V, ?nem Y, Ulcay A, Uzun G, Ay H, "Sudden hearing loss in a patient receiving piperacillin/tazobactam and daptomycin for diabetic foot infection", Scandinavian journal of infectious diseases, 2013 Mar .